Version 2.0.1 of the Alzheimer’s disease Therapeutic Area User Guide (TAUG-Alzheimer's) describes the most common biomedical concepts relevant to studies of Alzheimer’s disease and mild cognitive impairment, and the necessary metadata to represent such data consistently with Terminology and SDTM.
TAUG-Alzheimer’s v2.0.1 updates the document to remove draft domains that were included in v2.0. The most recent version of the draft domains are available on the CDISC Wiki .
TA Standards extend the Foundational Standards to represent data that pertain to specific indications within disease areas. CDISC Standards specify how to structure the data; they do not specify what data should be collected or how to conduct clinical trials, assessments or endpoints.
Public Review Comments
CDISC posts Public Review comments and resolutions to ensure transparency and show implementers how comments were addressed in the standard development process. v2.0 of the Public Review comments represent the substantive comments for this release as well.
